Michael P. Delaney

1.1k total citations
24 papers, 686 citations indexed

About

Michael P. Delaney is a scholar working on Nephrology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael P. Delaney has authored 24 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 5 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael P. Delaney's work include Dialysis and Renal Disease Management (7 papers), Parathyroid Disorders and Treatments (6 papers) and Chronic Kidney Disease and Diabetes (5 papers). Michael P. Delaney is often cited by papers focused on Dialysis and Renal Disease Management (7 papers), Parathyroid Disorders and Treatments (6 papers) and Chronic Kidney Disease and Diabetes (5 papers). Michael P. Delaney collaborates with scholars based in United Kingdom, Switzerland and United States. Michael P. Delaney's co-authors include Edmund J. Lamb, Paul E. Stevens, Shelagh O’Riordan, Gillian Eaglestone, Joanne L. Carter, Chris Farmer, Sarah Knight, R. Neil Dalton, Jean Irving and Andrew Davenport and has published in prestigious journals such as The FASEB Journal, Kidney International and Clinical Chemistry.

In The Last Decade

Michael P. Delaney

24 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Delaney United Kingdom	14	431	121	91	83	57	24	686
G Splendiani Italy	14	298 0.7×	81 0.7×	171 1.9×	139 1.7×	39 0.7×	52	608
Rajesh Mohandas United States	16	259 0.6×	132 1.1×	104 1.1×	109 1.3×	33 0.6×	49	593
Francesca Mallamaci Italy	2	310 0.7×	119 1.0×	79 0.9×	102 1.2×	32 0.6×	4	612
Maksimiljan Gorenjak Slovenia	18	386 0.9×	89 0.7×	128 1.4×	37 0.4×	100 1.8×	34	677
Adriano Luiz Ammirati Brazil	9	283 0.7×	66 0.5×	89 1.0×	85 1.0×	32 0.6×	16	527
Xiaoqiang Ding China	17	327 0.8×	76 0.6×	70 0.8×	137 1.7×	50 0.9×	39	738
Kirsten A. Armstrong Australia	13	252 0.6×	114 0.9×	98 1.1×	202 2.4×	28 0.5×	18	649
Amanda H. Anderson United States	12	688 1.6×	166 1.4×	103 1.1×	137 1.7×	35 0.6×	14	945
Ramón Saracho Spain	13	499 1.2×	64 0.5×	158 1.7×	136 1.6×	88 1.5×	28	828
Hung‐Chieh Yeh Taiwan	13	262 0.6×	65 0.5×	63 0.7×	100 1.2×	20 0.4×	36	478

Countries citing papers authored by Michael P. Delaney

Since Specialization

Citations

This map shows the geographic impact of Michael P. Delaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Delaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Delaney more than expected).

Fields of papers citing papers by Michael P. Delaney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Delaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Delaney. The network helps show where Michael P. Delaney may publish in the future.

Co-authorship network of co-authors of Michael P. Delaney

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Delaney. A scholar is included among the top collaborators of Michael P. Delaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Delaney. Michael P. Delaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Nayagam, Jeremy, Samuel McGrath, Mahmoud Montasser, et al.. (2020). Successful simultaneous liver-kidney transplantation for renal failure associated with hereditary complement C3 deficiency. American Journal of Transplantation. 20(8). 2260–2263. 2 indexed citations

2.

Stevens, Paul E., Gillian Eaglestone, Sarah Knight, et al.. (2018). Symmetric dimethylarginine is a stronger predictor of mortality risk than asymmetric dimethylarginine among older people with kidney disease. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 56(3). 367–374. 1 indexed citations

3.

Delaney, Michael P., et al.. (2016). The Health Economic Impact of Managing CMPA According To Guidelines: Challenging Current Treatment Practise In The UK. Value in Health. 19(7). A550–A550. 1 indexed citations

4.

Kelley, Stephen P., Alberto Contreras‐Sanz, Mark Kelly, et al.. (2014). Urinary ATP and visualization of intracellular bacteria: a superior diagnostic marker for recurrent UTI in renal transplant recipients?. SpringerPlus. 3(1). 200–200. 7 indexed citations

5.

Delaney, Michael P., Paul E. Stevens, Gillian Eaglestone, et al.. (2014). Serum Cystatin C Does Not Predict Mortality or Treatment Failure in Peritoneal Dialysis: A Prospective Study. Peritoneal Dialysis International. 36(1). 94–100. 3 indexed citations

6.

Stevens, Paul E., et al.. (2012). Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients. Kidney International. 82(1). 100–105. 37 indexed citations

7.

Stevens, Paul E., Gillian Eaglestone, Sarah Knight, et al.. (2012). Accuracy of the MDRD (Modification of Diet in Renal Disease) Study and CKD-EPI (CKD Epidemiology Collaboration) Equations for Estimation of GFR in the Elderly. American Journal of Kidney Diseases. 61(1). 57–66. 200 indexed citations

8.

Stevens, Paul E., et al.. (2010). Variability of Parathyroid Hormone and Other Markers of Bone Mineral Metabolism in Patients Receiving Hemodialysis. Clinical Journal of the American Society of Nephrology. 5(7). 1261–1267. 58 indexed citations

9.

Davenport, Andrew, et al.. (2010). Do Differences in Dialysis Prescription Impact on KDOQI Bone Mineral Targets? The Pan Thames Renal Audit. Blood Purification. 30(2). 111–117. 15 indexed citations

10.

Ray, Sumanta, Michael P. Delaney, & A F Muller. (2010). Proton pump inhibitors and acute interstitial nephritis. BMJ. 341(sep22 4). c4412–c4412. 37 indexed citations

11.

Davenport, Andrew, et al.. (2009). The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit. Nephrology Dialysis Transplantation. 25(3). 897–901. 46 indexed citations

12.

Eaglestone, Gillian, et al.. (2008). Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study. Nephrology Dialysis Transplantation. 23(11). 3554–3565. 19 indexed citations

13.

Delaney, Michael P., et al.. (2008). Relationship of Serum Cystatin C to Peritoneal and Renal Clearance Measures in Peritoneal Dialysis: A Cross-sectional Study. American Journal of Kidney Diseases. 51(2). 278–284. 28 indexed citations

14.

Eaglestone, Gillian, et al.. (2007). Chronic kidney disease prevalence in a UK residential care home population. Nephrology Dialysis Transplantation. 23(4). 1257–1264. 29 indexed citations

15.

Lamb, Edmund J., Shelagh O’Riordan, & Michael P. Delaney. (2003). Kidney function in older people: pathology, assessment and management. Clinica Chimica Acta. 334(1-2). 25–40. 78 indexed citations

16.

Delaney, Michael P., et al.. (2000). Constitutive and acquired resistance to calcineurin inhibitors in renal transplantation: role of P-glycoprotein-170. Transplant International. 13(4). 276–284. 13 indexed citations

17.

Delaney, Michael P., et al.. (2000). Constitutive and acquired resistance to calcineurin inhibitors in renal transplantation: role of P-glycoprotein-170. Transplant International. 13(4). 276–284. 11 indexed citations

18.

Delaney, Michael P., et al.. (1994). Cyclosporin A in refractory idiopathic nephrotic syndrome: 5 years clinical experience. Postgraduate Medical Journal. 70(830). 891–894. 1 indexed citations

19.

Glover, William, et al.. (1980). Radioimmunoassay of flurazepam in human plasma. Journal of Pharmaceutical Sciences. 69(5). 601–602. 19 indexed citations

20.

Dixon, Ross, William Glover, James V. Earley, & Michael P. Delaney. (1979). Desmethyldiazepam: A Specific Radioimmunoassay. Journal of Pharmaceutical Sciences. 68(11). 1471–1471. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact